Neurotrauma Reports, 2023 · DOI: 10.1089/neur.2023.0022 · Published: January 1, 2023
This article discusses the use of psychedelic substances by people with spinal cord injuries (SCI) and a unique set of adverse reactions reported by this group. These reactions include intense muscle spasms, sweating, and tremors, which are not typically reported by people without SCI using the same substances. The authors propose that these reactions may be due to a peripherally dominant serotonin syndrome-like clinical picture, where the increased sensitivity to serotonin caused by the spinal cord injury interacts with the effects of the psychedelic drugs. The study aims to raise awareness about this phenomenon to improve understanding of serotonergic psychedelics in the SCI population and to develop safer treatment protocols for those who choose to use them.
Development of specific guidelines for psychedelic-assisted therapy in individuals with SCI, addressing the unique risks and potential benefits.
Increased awareness and education for individuals with SCI who are considering or already using psychedelics, emphasizing potential adverse effects and safety measures.
Further research into the mechanisms underlying the peripherally dominant serotonin-like syndrome in SCI, including preclinical studies and clinical surveys.